{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:01Z","timestamp":1792788061913,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chinese Scholarship Council","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Chinese Scholarship Council","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Swedish Research Council","award":["2024-00429"],"award-info":[{"award-number":["2024-00429"]}],"id":[{"id":"https:\/\/ror.org\/03zttf063","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Wera Ekstr\u00f6ms Fond F\u00f6r Pediatrikforskning","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Fonden f\u00f6r Psykisk H\u00e4lsa","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Australian National Health and Medicine Research Council (NHMRC)-European Union Collaborative research grant","award":["APP2007048"],"award-info":[{"award-number":["APP2007048"]}]},{"name":"Australian National Health and Medicine Research Council (NHMRC)-European Union Collaborative research grant","award":["APP2007048"],"award-info":[{"award-number":["APP2007048"]}]},{"name":"UNSW Research Infrastructure Scheme","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"UNSW Research Infrastructure Scheme","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Nordforsk","award":["147386 and 230738"],"award-info":[{"award-number":["147386 and 230738"]}],"id":[{"id":"https:\/\/ror.org\/05bqzfg94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Swedish Research Council for Health, Working Life and Welfare","award":["2022-00126"],"award-info":[{"award-number":["2022-00126"]}]},{"name":"Medical Research Agency in Poland","award":["2021\/ABM\/02\/00006\/P\/03"],"award-info":[{"award-number":["2021\/ABM\/02\/00006\/P\/03"]}]},{"name":"Sawmill-owner Jeppe Juhl\u2019s and wife Ovita Juhl\u2019s Fund","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"The Capital Region","award":["22042850"],"award-info":[{"award-number":["22042850"]}]},{"name":"Greater Copenhagen Health Science Partners","award":["A7763"],"award-info":[{"award-number":["A7763"]}],"id":[{"id":"https:\/\/ror.org\/02ebqtm87","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["965381"],"award-info":[{"award-number":["965381"]}]},{"name":"NIH\/NIMH grants","award":["U01AR076092, R01MH116037, 1R01NS128535, R01MH131685, 1R01MH130899, U01MH135970"],"award-info":[{"award-number":["U01AR076092, R01MH116037, 1R01NS128535, R01MH131685, 1R01MH130899, U01MH135970"]}]},{"name":"Massachusetts General","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Otsuka Pharmaceuticals","award":["OAK-ISS-2023-001796"],"award-info":[{"award-number":["OAK-ISS-2023-001796"]}],"id":[{"id":"https:\/\/ror.org\/04tqd7s80","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Oregon Health & Science University and Supernus Pharmaceuticals","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"https:\/\/ror.org\/009avj582","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Union Horizon 2020 Research and Innovation Programme","award":["965381"],"award-info":[{"award-number":["965381"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]},{"name":"NHMRC Centre of Research Excellence in Medicines Intelligence","award":["1196900"],"award-info":[{"award-number":["1196900"]}]},{"name":"Nordforsk","award":["164218"],"award-info":[{"award-number":["164218"]}],"id":[{"id":"https:\/\/ror.org\/05bqzfg94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Swedish Society for Medical Research","award":["PD20-0036"],"award-info":[{"award-number":["PD20-0036"]}],"id":[{"id":"https:\/\/ror.org\/0433fd238","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008738","name":"Jeanssons Stiftelser","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100008738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Attention-deficit\/hyperactivity disorder (ADHD) has been linked to elevated risk of type 2 diabetes (T2D). However, the impact of ADHD and ADHD medication use on prognosis and health outcomes in T2D remains unclear. This study investigates the associations of (1) ADHD and (2) ADHD medication use with rates of major adverse cardiac events (MACE) and all-cause mortality after a T2D diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multinational cohort study used population-based data from Australia, Denmark, the Netherlands, Norway, Sweden, the United Kingdom, and the United States. Using a standardized analytical protocol, we identified adults with a first recorded T2D diagnosis during 2010-2020. Exposures were (1) ADHD, defined by a recorded ADHD diagnosis or ADHD medication dispensation, and (2) among adults with ADHD, the use of ADHD medication, both analysed as time-varying exposures. Main outcomes were MACE (acute myocardial infarction, stroke, or cardiovascular disease-related death) and all-cause mortality after T2D diagnosis. Cause-specific Cox models estimated hazard ratios (HRs) with 95% confidence intervals (CIs); results were pooled using random-effects meta-analyses and stratified by age and sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort included 1,929,027 adults with T2D (909,176 [47.1%] males). In pooled analyses, adults with T2D and ADHD had a higher rate of all-cause mortality (HR, 2.42; 95% CI, 1.72-3.41), but not MACE (HR, 1.04; 95% CI, 0.81-1.35), after a T2D diagnosis compared with those without ADHD. Among adults with T2D and ADHD, ADHD medication use was associated with higher rate of MACE in those diagnosed with T2D before age 45 years (HR, 1.58; 95% CI, 1.18-2.10). These associations remained consistent, after adjusting for sex, age, calendar year at T2D diagnosis, psychiatric history, other psychotropic medication use, and cardiometabolic medication use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adults with T2D and co-occurring ADHD were found to have increased risk of all-cause mortality after T2D diagnosis, while ADHD was not consistently associated with MACE across countries. ADHD medication use was linked to higher rate of MACE in adults with early-onset T2D. These findings suggest the potential need for integrated somatic-psychiatric care and careful consideration of ADHD medication use that may help reduce MACE and mortality, particularly in younger-onset T2D.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-026-05246-4","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:53:53Z","timestamp":1790394833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Major adverse cardiac events and mortality associated with ADHD and its treatment in adults with type 2 diabetes: a multi-national cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Zihan","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aske","family":"Astrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Engeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm B.","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Lunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Zhang-James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabell","family":"Brikell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Butwicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Dalsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"D\u2019Onofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen V.","family":"Faraone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soffia","family":"Gudbjornsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Haavik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Kuja-Halkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Klungs\u00f8yr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K. C.","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallie-Anne","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Sarsembayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C. K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Zoega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Snieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina A.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebba","family":"Du Rietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"5246_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-024-00495-0","volume":"10","author":"SV Faraone","year":"2024","unstructured":"Faraone SV, Bellgrove MA, Brikell I, Cortese S, Hartman CA, Hollis C, et al. Attention-deficit\/hyperactivity disorder. Nat Rev Dis Primers. 2024;10:11 https:\/\/doi.org\/10.1038\/s41572-024-00495-0","journal-title":"Nat Rev Dis Primers"},{"key":"5246_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101780","volume":"58","author":"AYL Chan","year":"2023","unstructured":"Chan AYL, Ma TT, Lau WCY, Ip P, Coghill D, Gao L, et al. Attention-deficit\/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study. EClinicalMedicine. 2023;58:101780 https:\/\/doi.org\/10.1016\/j.eclinm.2022.101780","journal-title":"EClinicalMedicine"},{"key":"5246_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S2215-0366(23)00332-2","volume":"11","author":"I Brikell","year":"2023","unstructured":"Brikell I, Yao H, Li L, Astrup A, Gao L, Gillies MB, et al. ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases. Lancet Psychiatry. 2023;11:16\u201326. https:\/\/doi.org\/10.1016\/S2215-0366(23)00332-2","journal-title":"Lancet Psychiatry"},{"key":"5246_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105076","volume":"147","author":"M Garcia-Argibay","year":"2023","unstructured":"Garcia-Argibay M, Li L, Du Rietz E, Zhang L, Yao H, Jendle J, et al. The association between type 2 diabetes and attention- deficit\/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study. Neurosci Biobehav Rev. 2023;147:105076 https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105076","journal-title":"Neurosci Biobehav Rev"},{"key":"5246_CR5","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S2215-0366(21)00171-1","volume":"8","author":"E Du Rietz","year":"2021","unstructured":"Du Rietz E, Brikell I, Butwicka A, Leone M, Chang Z, Cortese S, et al. Mapping phenotypic and aetiological associations between ADHD and physical conditions in adulthood in Sweden: A genetically informed register study. Lancet Psychiatry. 2021;8:774\u201383. https:\/\/doi.org\/10.1016\/S2215-0366(21)00171-1","journal-title":"Lancet Psychiatry"},{"key":"5246_CR6","doi-asserted-by":"publisher","first-page":"e0204516","DOI":"10.1371\/journal.pone.0204516","volume":"13","author":"Q Chen","year":"2018","unstructured":"Chen Q, Hartman CA, Haavik J, Harro J, Klungs\u00f8yr K, Hegvik TA, et al. Common psychiatric and metabolic comorbidity of adult attention-deficit\/hyperactivity disorder: A population-based cross-sectional study. PLoS One. 2018;13:e0204516 https:\/\/doi.org\/10.1371\/journal.pone.0204516","journal-title":"PLoS One"},{"key":"5246_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/acps.13694","volume":"150","author":"B Libutzki","year":"2024","unstructured":"Libutzki B, Neukirch B, Reif A, Hartman CA. Somatic burden of attention-deficit\/hyperactivity disorder across the lifecourse. Acta Psychiatr Scand. 2024;150:105\u201317. https:\/\/doi.org\/10.1111\/acps.13694","journal-title":"Acta Psychiatr Scand"},{"key":"5246_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2047487319878371","volume":"26","author":"E Dal Canto","year":"2019","unstructured":"Dal Canto E, Ceriello A, Ryd\u00e9n L, Ferrini M, Hansen TB, Schnell O, et al. Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26:25\u201332. https:\/\/doi.org\/10.1177\/2047487319878371","journal-title":"Eur J Prev Cardiol"},{"key":"5246_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/1474651413495703","volume":"13","author":"C Nwaneri","year":"2013","unstructured":"Nwaneri C, Cooper H, Bowen-Jones D. Mortality in type 2 diabetes mellitus: Magnitude of the evidence from a systematic review and meta-analysis. Br J Diabetes Vasc Dis. 2013;13:192\u2013207. https:\/\/doi.org\/10.1177\/1474651413495703","journal-title":"Br J Diabetes Vasc Dis"},{"key":"5246_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84985-x","volume":"15","author":"A Mader","year":"2025","unstructured":"Mader A, Haeberli D, Larcher B, Dopheide JF, Saely CH, Heinzle CF, et al. Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis. Sci Rep. 2025;15:2792 https:\/\/doi.org\/10.1038\/s41598-024-84985-x","journal-title":"Sci Rep"},{"key":"5246_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/jcv2.12158","volume":"3","author":"L Li","year":"2023","unstructured":"Li L, Yao H, Zhang L, Garcia-Argibay M, Du Rietz E, Brikell I, et al. Attention-deficit\/hyperactivity disorder is associated with increased risk of cardiovascular diseases: A systematic review and meta-analysis. JCPP Adv. 2023;3:e12158 https:\/\/doi.org\/10.1002\/jcv2.12158","journal-title":"JCPP Adv"},{"key":"5246_CR12","doi-asserted-by":"publisher","first-page":"e216401","DOI":"10.1001\/jamapediatrics.2021.6401","volume":"176","author":"F Catal\u00e1-L\u00f3pez","year":"2022","unstructured":"Catal\u00e1-L\u00f3pez F, Hutton B, Page MJ, Driver JA, Ridao M, Alonso-Arroyo A, et al. Mortality in Persons with Autism Spectrum Disorder or Attention-Deficit\/Hyperactivity Disorder: A Systematic Review and Meta-analysis. JAMA Pediatr. 2022;176:e216401 https:\/\/doi.org\/10.1001\/jamapediatrics.2021.6401","journal-title":"JAMA Pediatr"},{"key":"5246_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1001\/jamapsychiatry.2023.4294","volume":"81","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li L, Andell P, Garcia-Argibay M, Quinn PD, D\u2019Onofrio BM, et al. Attention-deficit\/hyperactivity disorder medications and long-term risk of cardiovascular diseases. JAMA Psychiatry. 2023;81:178\u201387. https:\/\/doi.org\/10.1001\/jamapsychiatry.2023.4294","journal-title":"JAMA Psychiatry"},{"key":"5246_CR14","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/j.jacc.2024.03.375","volume":"83","author":"A Holt","year":"2024","unstructured":"Holt A, Strange JE, Rasmussen PV, Nouhravesh N, Nielsen SK, Sindet-Pedersen C, et al. Long-term cardiovascular risk associated with treatment of attention-deficit\/hyperactivity disorder in adults. J Am Coll Cardiol. 2024;83:1870\u201382. https:\/\/doi.org\/10.1016\/j.jacc.2024.03.375","journal-title":"J Am Coll Cardiol"},{"key":"5246_CR15","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1001\/jama.2024.0851","volume":"331","author":"L Li","year":"2024","unstructured":"Li L, Zhu N, Zhang L, Kuja-Halkola R, D\u2019Onofrio BM, Brikell I, et al. ADHD pharmacotherapy and mortality in individuals with ADHD. JAMA. 2024;331:850\u201360. https:\/\/doi.org\/10.1001\/jama.2024.0851","journal-title":"JAMA"},{"key":"5246_CR16","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.2337\/dc23-S012","volume":"46","author":"NA Elsayed","year":"2023","unstructured":"Elsayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. Retinopathy, neuropathy, and foot Care: standards of care in diabetes\u20142023. Diabetes Care. 2023;46:S203\u201315. https:\/\/doi.org\/10.2337\/dc23-S012","journal-title":"Diabetes Care"},{"key":"5246_CR17","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s11892-014-0532-y","volume":"14","author":"DC Duke","year":"2014","unstructured":"Duke DC, Harris MA. Executive function, adherence, and glycemic control in adolescents with type 1 diabetes: A literature review. Curr Diab Rep. 2014;14:532 https:\/\/doi.org\/10.1007\/s11892-014-0532-y","journal-title":"Curr Diab Rep"},{"key":"5246_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2023.100318","volume":"32","author":"AZ Dehnavi","year":"2023","unstructured":"Dehnavi AZ, Zhang-James Y, Draytsel D, Carguello B, Faraone SV, Weinstock RS. Association of ADHD symptoms with type 2 diabetes and cardiovascular comorbidities in adults receiving outpatient diabetes care. J Clin Transl Endocrinol. 2023;32:100318 https:\/\/doi.org\/10.1016\/j.jcte.2023.100318","journal-title":"J Clin Transl Endocrinol"},{"key":"5246_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/10870547241288720","volume":"29","author":"D Leshno","year":"2025","unstructured":"Leshno D, Lev Shalem L, Perlove Gavze R, Leshno M. Diabetes glycemic control in adults with type 2 diabetes mellitus and ADHD. J Atten Disord. 2025;29:101\u20136. https:\/\/doi.org\/10.1177\/10870547241288720","journal-title":"J Atten Disord"},{"key":"5246_CR20","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","volume":"13","author":"S Cuschieri","year":"2019","unstructured":"Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13:S31\u20134. https:\/\/doi.org\/10.4103\/sja.SJA_543_18","journal-title":"Saudi J Anaesth"},{"key":"5246_CR21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/pds.3459","volume":"22","author":"A Potteg\u00e5rd","year":"2013","unstructured":"Potteg\u00e5rd A, Hallas J. Assigning exposure duration to single prescriptions by use of the waiting time distribution. Pharmacoepidemiol Drug Saf. 2013;22:803\u20139. https:\/\/doi.org\/10.1002\/pds.3459","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"5246_CR22","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1111\/bcp.13369","volume":"83","author":"J Brett","year":"2017","unstructured":"Brett J, Daniels B, Karanges EA, Buckley NA, Schneider C, Nassir A, et al. Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study. Br J Clin Pharmacol. 2017;83:2581\u20138. https:\/\/doi.org\/10.1111\/bcp.13369","journal-title":"Br J Clin Pharmacol"},{"key":"5246_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/00048674221114782","volume":"57","author":"C Bruno","year":"2023","unstructured":"Bruno C, Havard A, Gillies MB, Coghill D, Brett J, Guastella AJ, et al. Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013\u20132020). Aust N Z J Psychiatry. 2023;57:675\u201385. https:\/\/doi.org\/10.1177\/00048674221114782","journal-title":"Aust N Z J Psychiatry"},{"key":"5246_CR24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","volume":"9","author":"N Sattar","year":"2021","unstructured":"Sattar N, Lee MMY, Kristensen SL, Branch KRH, Del Prato S, Khurmi NS, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol. 2021;9:653\u201362. https:\/\/doi.org\/10.1016\/S2213-8587(21)00203-5","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5246_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/jcv2.70020","volume":"5","author":"H Larsson","year":"2025","unstructured":"Larsson H, Chang Z, Man KKC. Preregistration of high-quality protocols in pharmacoepidemiology research. JCPP Adv. 2025;5:e70020 https:\/\/doi.org\/10.1002\/jcv2.70020","journal-title":"JCPP Adv"},{"key":"5246_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Series B Stat Methodol. 1995;57:289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"5246_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1192\/bjp.2024.199","volume":"226","author":"E O\u2019Nions","year":"2025","unstructured":"O\u2019Nions E, El Baou C, John A, Lewer D, Mandy W, McKechnie DGJ, et al. Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: Matched cohort study. Br J Psychiatry. 2025;226:261\u20138. https:\/\/doi.org\/10.1192\/bjp.2024.199","journal-title":"Br J Psychiatry"},{"key":"5246_CR28","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/S0140-6736(14)61822-5","volume":"385","author":"SV Faraone","year":"2015","unstructured":"Faraone SV. Attention deficit hyperactivity disorder and premature death. Lancet. 2015;385:2132\u20133. https:\/\/doi.org\/10.1016\/S0140-6736(14)61822-5","journal-title":"Lancet"},{"key":"5246_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cbpra.2005.09.002","volume":"13","author":"LM Sanchez","year":"2006","unstructured":"Sanchez LM, Chronis AM, J. Hunter S. Improving compliance with diabetes management in young adolescents with attention-deficit\/hyperactivity disorder using behavior therapy. Cogn Behav Pract. 2006;13:134\u201345. https:\/\/doi.org\/10.1016\/j.cbpra.2005.09.002","journal-title":"Cogn Behav Pract"},{"key":"5246_CR30","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2024.1786","volume":"67","author":"S Popit","year":"2024","unstructured":"Popit S, Serod K, Locatelli I, Stuhec M. Prevalence of attention-deficit hyperactivity disorder (ADHD): systematic review and meta-analysis. Eur Psychiatry. 2024;67:e68 https:\/\/doi.org\/10.1192\/j.eurpsy.2024.1786","journal-title":"Eur Psychiatry"},{"key":"5246_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cger.2009.07.007","volume":"25","author":"A Yazdanyar","year":"2009","unstructured":"Yazdanyar A, Newman AB. The burden of cardiovascular disease in the elderly: Morbidity, mortality, and costs. Clin Geriatr Med. 2009;25:563\u201377. https:\/\/doi.org\/10.1016\/j.cger.2009.07.007","journal-title":"Clin Geriatr Med"},{"key":"5246_CR32","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.2337\/dc20-2375","volume":"44","author":"M Zhao","year":"2021","unstructured":"Zhao M, Song L, Sun L, Wang M, Wang C, Yao S, et al. Associations of type 2 diabetes onset age with cardiovascular disease and mortality: The Kailuan study. Diabetes Care. 2021;44:1426\u201332. https:\/\/doi.org\/10.2337\/dc20-2375","journal-title":"Diabetes Care"},{"key":"5246_CR33","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1016\/S0140-6736(25)01012-8","volume":"405","author":"LL Lim","year":"2025","unstructured":"Lim LL, Jones S, Cikomola JC, Hivert MF, Misra S. Understanding the drivers and consequences of early-onset type 2 diabetes. Lancet. 2025;405:2327\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(25)01012-8","journal-title":"Lancet"},{"key":"5246_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41574-020-0334-z","volume":"16","author":"DJ Magliano","year":"2020","unstructured":"Magliano DJ, Sacre JW, Harding JL, Gregg EW, Zimmet PZ, Shaw JE. Young-onset type 2 diabetes mellitus \u2014 implications for morbidity and mortality. Nat Rev Endocrinol. 2020;16:321\u201331. https:\/\/doi.org\/10.1038\/s41574-020-0334-z","journal-title":"Nat Rev Endocrinol"},{"key":"5246_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/NDT.S59271","volume":"12","author":"T Torgersen","year":"2016","unstructured":"Torgersen T, Gjervan B, Lensing MB, Rasmussen K. Optimal management of ADHD in older adults. Neuropsychiatr Dis Treat. 2016;12:79\u201387. https:\/\/doi.org\/10.2147\/NDT.S59271","journal-title":"Neuropsychiatr Dis Treat"},{"key":"5246_CR36","doi-asserted-by":"publisher","first-page":"e301195","DOI":"10.1136\/bmjment-2024-301195","volume":"27","author":"Z Dong","year":"2024","unstructured":"Dong Z, Zhang L, Li L, Liu S, Brikell I, Kuja-Halkola R, et al. Cumulative ADHD medication use and risk of type 2 diabetes in adults: A Swedish Register study. BMJ Ment Health. 2024;27:e301195 https:\/\/doi.org\/10.1136\/bmjment-2024-301195","journal-title":"BMJ Ment Health"},{"key":"5246_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1176\/appi.ajp.2015.15020266","volume":"173","author":"S Cortese","year":"2016","unstructured":"Cortese S, Moreira-Maia CR, St Fleur D, Morcillo-Pe\u00f1alver C, Rohde LA, Faraone SV. Association between ADHD and obesity: A systematic review and meta-analysis. Am J Psychiatry. 2016;173:34\u201343. https:\/\/doi.org\/10.1176\/appi.ajp.2015.15020266","journal-title":"Am J Psychiatry"},{"key":"5246_CR38","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1093\/eurjpc\/zwac187","volume":"29","author":"F Lopez-Jimenez","year":"2022","unstructured":"Lopez-Jimenez F, Almahmeed W, Bays H, Cuevas A, Di Angelantonio E, le Roux CW, et al. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation. Eur J Prev Cardiol. 2022;29:2218\u201337. https:\/\/doi.org\/10.1093\/eurjpc\/zwac187","journal-title":"Eur J Prev Cardiol"},{"key":"5246_CR39","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/wps.21374","volume":"24","author":"S Cortese","year":"2025","unstructured":"Cortese S, Bellgrove MA, Brikell I, Franke B, Goodman DW, Hartman CA, et al. Attention-deficit\/hyperactivity disorder (ADHD) in adults: Evidence base, uncertainties and controversies. World Psychiatry. 2025;24:347\u201371. https:\/\/doi.org\/10.1002\/wps.21374","journal-title":"World Psychiatry"},{"key":"5246_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/acps.13804","volume":"152","author":"S Gr\u00f8ntved","year":"2025","unstructured":"Gr\u00f8ntved S, Hald K, Mohr-Jensen C, Johnsen SP, Mainz J, Valentin JB. Prevalence and Incidence of Attention Deficit\/Hyperactivity Disorder in Denmark. A National Register-Based Open Cohort Study. Acta Psychiatr Scand. 2025;152:27\u201338. https:\/\/doi.org\/10.1111\/acps.13804","journal-title":"Acta Psychiatr Scand"},{"key":"5246_CR41","doi-asserted-by":"publisher","first-page":"384","DOI":"10.5694\/mja2.70049","volume":"223","author":"RCJ Bradlow","year":"2025","unstructured":"Bradlow RCJ, Armstrong F, Ogden E. Adult attention deficit hyperactivity disorder in Australia: how its current commercial model for diagnosis and treatment is encouraging misdiagnosis. Med J Aust. 2025;223:384\u20136. https:\/\/doi.org\/10.5694\/mja2.70049","journal-title":"Med J Aust"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-05246-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:54:51Z","timestamp":1790654091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-05246-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5246"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-05246-4","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HL reports receiving grants from TAKEDA and Shire Pharmaceuticals; personal fees from and serving as a speaker for Medice, Shire\/Takeda Pharmaceuticals and Evolan Pharma AB; all outside the submitted work. HL is editor-in-chief of JCPP Advances. SVF reports personal fees and travel expenses from Mentavi\/ADHD Online, Axsome, Ironshore\/Collegium, KemPharm\/Corium, Noven, Supernus, Sandoz, Tris and Medice; has a US patent (via his institution) for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD (US20130217707 A1); receives royalties from books published by Guilford Press (Straight Talk about Your Child\u2019s Mental Health), Oxford University Press (Schizophrenia: The Facts), and Elsevier (ADHD: Non-Pharmacologic Interventions); and is program director of www.ADHDEvidence.org and www.ADHDinAdults.com. SVF also reports research funding from Massachusetts General, Otsuka Pharmaceuticals OAK-ISS-2023-001796, Oregon Health & Science University and Supernus Pharmaceuticals. SVF\u2019s continuing medical education programs are supported by, Collegium Pharmaceuticals, Corium Pharmaceuticals, Tris Pharmaceuticals and The Upstate Foundation. All outside the submitted work. ICKW reports research funding from Amgen and GSK, the Hong Kong Research Grants Council, the Hong Kong Health and Medical Research Fund, the National Institute for Health Research in England, the European Commission, and the National Health and Medical Research Council in Australia, consulting fees from IQVIA and World Health Organization, outside of the submitted work. ICKW is a non-executive director of Jacobson Medical, Advance Data Analytics for Medical Science (ADAMS) Limited in Hong Kong and OCUS Innovation Limited (HK, Ireland and UK); a former director of Therakind in England and Asia Medicine Regulatory Affairs (AMERA) Services Limited in Hong Kong. ZC received lecture honoraria from TAKEDA Pharmaceuticals, outside the submitted work. AB acknowledged lecture honorarium from WCG PHARMA, Tomasz Gizi\u0144ski, Poland outside the submitted work. KKCM reports grants from CW Maplethorpe Fellowship, IQVIA, the European Union Horizon 2020, the UK NIHR and the Hong Kong Research Grant Council and Hong Kong Innovation and Technology Commission; all outside the submitted work. MBG, MA and SAP report that the Medicines Intelligence Research Program, School of Population Health, the University of New South Wales (UNSW) has received research funding from IQVIA Australia, unrelated to this project. JH received lecture honoraria from Medice, outside the submitted work. All other authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"527"}}